ERBB2 and non-small cell lung carcinoma: For example, overexpression of the EGFR family member ERBB2/HER2/NEU, which activates the PI3K/Akt pathway, is associated with platinum resistance in ovarian, NSCLC, and HNSCC cancer patients (Supplementary Table S1).